Global SYMPLICITY Registry (GSR) DEFINE

Condition(s) studied

Investigational drug(s) / intervention(s)

Medtronic Renal Denervation System: The Symplicity renal denervation system is comprised of a single-use, disposable catheter and a reusable radiofrequency (RF) generator. The Symplicity renal denervation system has CE Marking for the intended use of delivering low-level radiofrequency energy through the wall of the renal artery to denervate the human kidney.

Study summary

This is a prospective, multi-center, single-arm, non-interventional and open-label registry. The purpose of the registry is to document the long-term safety and effectiveness of renal denervation in a real world patient population with hypertension GSR DEFINE is the continuation of the Global SYMPLICITY Registry and collectively will enroll approximately 5000 patients with hypertension who undergo the renal denervation procedure, from over 300 sites worldwide. Subjects included in GSR DEFINE will be followed for a minimum of 1 year and up to 5 years post-procedure. Patients with uncontrolled hypertension will be enrolled in accordance with the inclusion criteria specified in the protocol.

Eligibility

Primary outcome measure(s)

• BP Measurements — 6 months
  Blood pressure changes from baseline (Office Setting and 24-hr Ambulatory measurements)

Trial sites (2)

More Medtronic Vascular trials in Germany

Other trials for the same condition